oin Vic Senese, RN, BSN, FAUNA, host of UroPatient, as we dive deep into Optilume, the innovative minimally invasive treatment for benign prostatic hyperplasia (BPH). In this episode, Vic explains how Optilume works, the latest clinical evidence, patient outcomes, and why it may be a game-changer in BPH management.
We discuss:
How Optilume differs from traditional BPH treatments like TURP and medications
The mechanism behind drug-coated balloon technology
Recovery times, side effects, and patient satisfaction
Real-world results and future implications for urology
Whether you are a patient exploring treatment options or a healthcare professional keeping up with advances in urologic care, this video is packed with insights and expert perspectives.
Subscribe to my channel for more updates on urology innovations, patient care tips, and expert discussions: https://www.youtube.com/@UroNurse1
The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.